Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00207493 · ClinicalTrials.gov registry record · Phase 1

The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.

A Phase 1 study, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
Phase 1
Development phase
494
Enrollment target

NCT00207493 is a Phase 1 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 494 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00207493, a Phase 1 study, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
Phase 1
Development phase
494 participants
Enrollment target

Study Summary

Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation. This project tests an enhancement to the materials provided to patients to help convince their partners to seek evaluation against the standard of care, which is a brief notification instruction. The desired outcomes are greater levels of notification by participants of their partners and lower levels of reinfection among participants.

Interventions

  • BEHAVIORAL Kit enhancement to referral
  • PROCEDURE patient referral versus contract referral

Trial Details

FieldValue
Enrollment Target 494 participants
Start Date 2000-10
Est. Completion 2007-09
Phase Phase 1

What the Registry Record Tells You About NCT00207493

The ClinicalTrials.gov registry entry for NCT00207493 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Kit enhancement to referral is the first listed.

NCT00207493 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00207493 about?

NCT00207493 is a clinical study titled "The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.". Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation. This project tests an enhancement to the materials provided to patients to help convince their partners to seek evaluation against the stand...

What is the current status of trial NCT00207493?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 494 participants. The study started on 2000-10. Estimated completion is 2007-09.

What interventions are being tested in trial NCT00207493?

The interventions under investigation include: Kit enhancement to referral (BEHAVIORAL), patient referral versus contract referral (PROCEDURE).

Who is sponsoring clinical trial NCT00207493?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.